In this free webinar, take a deep dive into the current advancements in patient-centric precision medicine for neurogenerative diseases. Attendees will gain insights into the treatments for neurodegenerative disorders and the crucial role of biomarkers. The featured speakers will share the importance of incorporating patient and caregiver input into the design and execution of neurodegenerative disease clinical trials.
TORONTO, June 25, 2024 /PRNewswire-PRWeb/ -- Neurodegenerative diseases are one of the most challenging conditions not only for the patients but also for caregivers, healthcare providers and the healthcare systems. Over the past few decades, there has been a major focus to drive the science and research in the field, leading to better and more precise treatment options for patients.
However, there is a stronger need to incorporate patients' and carers' voices to inform each stage of value creation, from scientific discovery to providing access to new treatment options. This webinar brings experienced voices across the pharma industry and patient organizations to put a spotlight on patient-centric approaches in clinical research for neurodegenerative disorders.
The expert speakers will explore the latest advancements in patient-centric precision medicine, focusing on the use of fluid and imaging biomarkers for identifying patients, stratifying them and monitoring their treatment responses.
It will delve into the treatments for neurodegenerative disorders and the critical role that biomarkers play in these processes, discussing why extensive patient participation is necessary. Moreover, the importance of incorporating patient and caregiver input into the design and execution of clinical trials for neurodegenerative diseases will be emphasized, highlighting how such integration can enhance trial effectiveness and patient outcomes.
Register for this webinar today to understand how to integrate patient-centric approaches in clinical research for neurodegenerative diseases.
Join Vikas Mohan Sharma, MD, Global Head of Neuroscience and Ophthalmology, Fortrea (Moderator); Dr. William Potter, MD, PhD, Independent expert (retired from NIMH, Lilly, and Merck); Dr. Hartmuth Kolb, PhD, CSO, Enigma Biomedical Group (EBG), USA; and Shana Dodge, PhD, Director of Research Engagement at the Association for Frontotemporal Degeneration (AFTD), for the live webinar on Thursday, July 11, 2024, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Patient Centricity in Neurodegenerative Diseases.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Soumya Shashikumar, Xtalks, +1 (416) 977-6555 x371, skumar@xtalks.com, https://xtalks.com
SOURCE Xtalks
